EP. 1: ESA-Ineligible LR MDS patient with Transfusion-Dependent AnemiaByAbdulraheem Yacoub, MDAugust 14th 2024
EP. 4: Efficacy and Safety of Imetelstat in ESA- ineligible patientsByAbdulraheem Yacoub, MDAugust 14th 2024
EP. 6: Comparing Telomerase Inhibitors and EMAs in ESA-Ineligible LR MDSByAbdulraheem Yacoub, MDAugust 14th 2024
EP. 7: 74- year-old man with LRMDS and Transfusion Dependent AnemiaByAbdulraheem Yacoub, MDAugust 14th 2024
EP. 9: EMA vs Telomerase Inhibitor for RS+ patients after ESA failureByAbdulraheem Yacoub, MDAugust 14th 2024
EP. 10: Optimizing Anemia Management and Addressing Unmet Needs in LR MDSByAbdulraheem Yacoub, MDAugust 14th 2024
